Abstract:Background: Prostate cancer (PCa) is the second leading cause of cancer-related deaths among men worldwide. Immunotherapy is an emerging treatment modality for cancers that harnesses the immune system's ability to eliminate tumor cells. In particular, dendritic cell (DC) vaccines, have demonstrated promise in eliciting a tumor-specific immune response. In this study, we investigated the potential of using DCs loaded with the MAGE-A2 long peptide to activate T cell cytotoxicity toward PCa cell lines. Methods: Here, we generated DCs from monocytes and thoroughly characterized their phenotypic and functional properties. Then, DCs were pulsed with MAGE-A2 long peptide (LP) as an antigen source, and monitored for their transition from immature to mature DCs by assessing the expression levels of several costimulatory and maturation molecules like CD14, HLA-DR, CD40, CD11c, CD80, CD83, CD86, and CCR7. Furthermore, the ability of MAGE-A2 -LP pulsed DCs to stimulate T cell proliferation in a mixed lymphocyte reaction (MLR) setting and induction of cytotoxic T cells (CTLs) in coculture with autologous T cells were examined. Finally, CTLs were evaluated for their capacity to produce interferon-gamma (IFN-γ) and kill PCa cell lines (PC3 and LNCaP). Results: The results demonstrated that the antigen-pulsed DCs exhibited a strong ability to stimulate the expansion of T cells. Moreover, the induced CTLs displayed substantial cytotoxicity against the target cells and exhibited increased IFN-γ production during activation compared to the controls. Conclusions: Overall, this innovative approach proved efficacious in targeting PCa cell lines, showcasing its potential as a foundation for the development and improved PCa cancer immunotherapy.

Research of dendritic cells pulsed with PSA peptide inducing specific CTL in vitro

Progress on Dendritic Cell Vaccines in Tumor Immunotherapy

Vaccination with A Dna Vaccine Based on Human Psca and Hsp70 Adjuvant Enhances the Antigen-Specific Cd8(+) T-Cell Response and Inhibits the Psca(+) Tumors Growth in Mice

Dendritic Cells Transduced with a PSMA-encoding Adenovirus and Cocultured with Autologous Cytokine-Induced Lymphocytes Induce a Specific and Strong Immune Response Against Prostate Cancer Cells.

[Autologous lung cancer tissues derived gp96-peptide complex/dendritic cell vaccine induces the cytotoxic T cell response in vitro].

The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors

A Modified HLA-A*0201-restricted CTL Epitope from Human Oncoprotein (hpebp4) Induces More Efficient Antitumor Responses

The Effect of Dendritic Cells Pulsed with Antigens on Cytokines Induced Killer Cells

Antitumor Effects of Ad-PSMA-Pulsed Dendritic Cells Cocultured with Autologous Cytokine-Induced Killer Cells on Prostate Cancer in Vivo

Antitumor Immunity by a Dendritic Cell Vaccine Encoding Secondary Lymphoid Chemokine and Tumor Lysate on Murine Prostate Cancer

Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy

In Vivo and in Vitro Activation of CTL by Murine Dendritic Cells Pulsed with Acid Eluted Tumor Antigen Peptides

Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis

Induction of tumor-specific cytotoxic T lymphocytes in vitro by dendritic cells pulsed with different glioma antigens

Tumor Antigen-Pulsed Dendritic Cell Vaccine for Treatment of Patients with Advanced Malignant Tumor:A Clinical Observation

Effect of dendritic cells sensitized by tumor cells lysates on the murine breast cancer

Cytotoxic T-lymphocytes Response in Vitro Activated by Dendritic Cells Pulsed with Heat Shock Protein 70 Derived from Human Bladder Tumor Cell Lines of EJ

TGF-β insensitive dendritic cells: an efficient vaccine for murine prostate cancer

Dendritic Cells Pulsed with Α‐fetoprotein and Mutant P53 Fused Gene Induce Bi‐targeted Cytotoxic T Lymphocyte Response Against Hepatic Carcinoma

[Antitumor Immune Responses Induced by Idiotype-Pulsed Dendritic Cells with Cell-Penetrating Peptide Vaccination in Vivo].

High potency and specific tumoricidal activity of HAS-stimulated lymphocytes induced by tumor antigen pulsed dendritic cells